Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Palliative Care for Inclusion Body Myositis, a Case Report

Kamini E. Kuchinad, MD, MPH, Ambereen Mehta, MD, MPH, David Wu, MD, & Jemima Albayda, MD  |  Issue: September 2024  |  September 7, 2024

When Mrs. F needed to make healthcare decisions, she struggled with the uncertainty surrounding her husband’s prognosis. Incorporation of goals-of-care discussions earlier in the course of his illness would have allowed them to have relevant discussions surrounding therapies and advance care planning.10 High-quality communication surrounding goals of care in the management of serious illness are associated with improved quality of life and quality of death, and lead to reduced healthcare interventions.11–13

Once Mr. F was unable to travel for specialty care, the communication divide worsened because he lacked a regular longitudinal provider who was well versed in his disease. Incorporating telemedicine into the care of IBM patients may allow consistent communication, even when patients can’t attend visits in person, and decrease the sense of medical isolation.14

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Care-partner burnout is a significant unmet need.

Palliative care incorporates management of interpersonal issues, such as care-partner burnout; for Mrs. F, her care-partner burnout was unaddressed. Studies suggest that care partners of individuals with IBM, as well as other inflammatory myopathies, face significant burden.15 Like up to half of family care partners, Mrs. F began to experience significant depression and anxiety, which went unaddressed as her husband’s health issues took the spotlight.16–18

Physicians have the opportunity to support care partners and minimize some of the burden they experience throughout the journey of illness by providing excellent communication, facilitating advance care planning and decision making, facilitating home care/respite care and providing emotional support.16 Support groups may also be helpful for the patient and family.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
Multidisciplinary care is essential in complex illness management.

The support of social workers is often needed to navigate the complexity of the healthcare system and obtain needed resources. Without these structural supports, individuals like Mr. F are often left to ascertain which tools and equipment are needed to manage their mobility deficits without professional guidance, leading to ineffective and expensive efforts while potentially worsening deficits.

Individuals affected by IBM also face significant economic burden, including costs related to specialized equipment, home modifications and paid professional help.19 Prompt referral to social work can ease the burden that individuals with IBM and their families face in caring for their disease. In fact, a recent randomized controlled trial found that a nursing and social work palliative care telehealth team improved quality of life for individuals with serious chronic illness.20

Learn from Other Specialties

Understanding when to refer patients to palliative care specialists can be beneficial, helping patients with IBM receive appropriate care. Prior studies have found specialty palliative care is underutilized for patients with IBM admitted to the hospital, resulting in a missed opportunity to provide multidisciplinary quality care.21

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ConditionsMyositis Tagged with:case reportEditor's Pickinclusion body myositis (IBM)palliative care

Related Articles

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Myositis Mysteries

    January 1, 2008

    Why isn’t my myositis patient getting better?

    Autoantibodies in Autoimmune Myopathy

    Autoantibodies in Autoimmune Myopathy

    September 18, 2017

    In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

    Tashatuvango / shutterstock.com

    Myositis-Specific Antibodies Identified

    January 16, 2020

    The idiopathic inflammatory myopathies (IIM) encompass eight categories: 1) dermatomyositis (DM) in adults, 2) juvenile dermatomyositis, 3) amyopathic DM, 4) cancer-associated DM, 5) polymyositis, 6) immune-mediated necrotizing myopathy, 7) inclusion body myositis, and 8) overlap myositis.1 These categories help classify the myopathies based on clinical and histologic features. The incidence of IIM is estimated at…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences